Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is Smith & Nephew a hidden defensive gem in the UK stock market?

Is LSE:SN - Smith & Nephew stock rising today due to defensive investing trends and healthcare sector strength?

Ankur Sharma | 24 March 2026

How Does Syncona Create Value in Life Sciences?

OverviewSyncona Limitedis a UK-listed investment trust focused on building and scaling innovative life sciences companies. The firm primarily invests in early-stage and clinical-stage biotechnology businesses, targeting breakthrough therapies across areas such as gene therapy, oncology, and rare diseases. Its model involves identifying promising scientific …

Team Kalkine | 24 March 2026

Should investors consider CVS Group in healthcare portfolios?

CVS Group PLCis one of the largest integrated veterinary service providers in the UK, offering a comprehensive range of services including clinical care, diagnostics, laboratories, and pet crematoria. The company has expanded significantly through acquisitions of independent veterinary practices, building a vertically integrated model …

Team Kalkine | 24 March 2026

Can Healthcare Demand Boost Convatec’s Growth Potential?

Convatec Group has demonstrated consistent operational progress, supported by steady demand across its core segments such as advanced wound care, ostomy care, continence care, and infusion therapies. The essential nature of these products ensures recurring demand, which contributes to stable revenue visibility.

Team Kalkine | 24 March 2026

Is Hikma Pharmaceuticals a Smart Buy After Today’s Dip?

Why is LSE:HIK - Hikma Pharmaceuticals stock down today on 23 March 2026 despite stable fundamentals?

Ankur Sharma | 23 March 2026

Is Dilution Hurting Trellus Health Stock?

Trellus Health develops digital solutions such as theTrellus Elevateplatform, targeting chronic conditions like inflammatory bowel disease, and operates within theHealthcare – Digital Health / HealthTechsector.

Team Kalkine | 23 March 2026

Is Oxford BioMedica Positioned for a Valuation Re-Rating?

Oxford BioMedica plcis a leading biotechnology company focused on cell and gene therapy, with core expertise in viral vector development and manufacturing. The company has transitioned into a Contract Development and Manufacturing Organisation (CDMO), allowing it to generate more predictable, contract-based revenues. Its proprietary …

Team Kalkine | 23 March 2026

Bellevue Healthcare Trust Stock Dips: Is This a Buying Opportunity in Healthcare?

Bellevue Healthcare Trust PLC(LON:BBH) edged lower by 1.25% on March 23, 2026, with shares trading at 126.20 GBX.

Team Kalkine | 23 March 2026

What’s Behind the Massive Drop in Spire Healthcare Shares?

The primary catalyst behind today’s sharp drop in LSE:SPI is likelyearnings-related disappointment and weaker forward outlook.

Team Kalkine | 23 March 2026

Are Investors Betting Big on LSE:IMM Ahead of Major Clinical Updates?

ImmuPharma stock surge March 2026, FTSE biotech rally, UK small-cap biotech momentum, Lupuzor clinical updates, autoimmune drug development pipeline, FTSE AIM biotech stocks rising, UK pharma penny stocks trending — these are the dominant SEO keywords shaping current investor interest in LSE:IMM - ImmuPharma …

Ankur Sharma | 23 March 2026
Support

Hi! How can we help you today?

Loading…